Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Guidance
  • News

Honeywell FY23 Outlook: Revenue $36.0B – $37.0B Vs. $36.94B Estimate, Adj EPS $8.80 – $9.20 Vs. $9.14 Estimate

By Benzinga Newsdesk
February 2, 7:34 AM
TABLE 1: FULL-YEAR 2023 GUIDANCE2  Sales   $36.0B - $37.0B Organic Growth   2% - 5% Segment

HON

Read More
1 minute read
  • Guidance
  • News

Prestige Consumer Healthcare FY23 Revenue Outlook $1.120B – $1.122B Vs. $1.12B Estimate

By Benzinga Newsdesk
February 2, 7:08 AM
"With one quarter to go in fiscal year 2023 we anticipate sales between $1,120 and $1,122 equating to over 3% growth on top of our record fiscal 2022 results. Looking ahead, our proven business strategy, portfolio

PBH

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Guidance
  • News
  • Reiteration
  • Social Media
  • Tech

Zuckerberg Emulating How Tim Cook Runs Apple? Why Meta Analyst Sees Short-Term Strength

By Shanthi Rexaline
February 2, 2:47 AM
Meta Platforms Inc.

META

Read More
1 minute read
  • Earnings
  • Guidance
  • M&A
  • News

Reported Late Wednesday, Ouster Achieved FY22 Revenue Guidance Of $40M-55M And 25%-30% In Gross Margins; Velodyne Exceeded Its Q4 22 Revenue Guidance Of $12M-14M

By Happy Mohamed
February 2, 2:00 AM
Fourth Quarter and Fiscal Year 2022 Financial Results Ouster achieved its Fiscal Year 2022 guidance of $40 to $55 million in revenue and 25% to 30% in gross

OUST

Read More
2 minute read
  • After-Hours Center
  • Earnings
  • General
  • Guidance
  • News
  • Social Media
  • Tech
  • Top Stories

Zuckerberg Eyes Slice Of AI Pie Amid ChatGPT Craze: ‘One Of My Goals For Meta Is…’

By Shivdeep Dhaliwal
February 1, 10:26 PM
Meta Platforms Inc (NASDAQ: META) CEO Mark Zuckerberg touched on the role of artificial intelligence in upcoming products and the transformation of its apps at the company’s

META

Read More
1 minute read
  • Guidance
  • News

Corteva Sees FY23 EPS $2.70-$2.90 Vs $3.13 Est.; FY23 Revenue $18.1B-$18.4B Vs $18.49B Est

By Happy Mohamed
February 1, 6:04 PM
2023 Guidance The outlook for agriculture remains robust in 2023, with record demand for grain and oilseeds as ending stocks continue to be under pressure. Commodity prices are above historical averages,

CTVA

Read More
1 minute read
  • Guidance
  • News

MetLife Sees FY23 Adj. Earnings Of $1B-$1.2B, Sees Corporate And Other Adj. Earnings Of $650M-$750M In 2023

By Michael Horton
February 1, 5:49 PM
-Reuters

MET

Read More
1 minute read
  • Earnings
  • Guidance
  • News

Goal Acquisitions Corp. In Shareholder Letter Gives Preliminary Estimated Gross Revenue Of €436M; Net Income Of €26M

By Happy Mohamed
February 1, 5:39 PM
The Company itself is no stranger to down markets and has a proven track record of financial success in a variety of economic environments, with preliminary estimates for 2022 gross revenue, net income, and adjusted

PUCK

Read More
1 minute read
  • Guidance
  • News

MaxLinear Sees Q1 Revenue Of $240M-$260M Vs $279.7M Est

By Happy Mohamed
February 1, 5:13 PM
First Quarter 2023 Business Outlook The company expects revenue in the first quarter 2023 to be approximately $240 million to $260 million. The Company also estimates the

MXL

Read More
2 minute read
  • Cannabis
  • Global
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents

By Lara Goldstein
February 1, 4:47 PM
After the positive results provided by its clinical trial assessing novel DMT’s effects on patients with Major Depressive Disorder (MDD), psychedelics biotech Small Pharma Inc.

DMTTF

Posts pagination

Previous 1 … 504 505 506 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service